Microbe of the Month: Reinforcing a gutsy resistance fighter: The more bifidobacteria in our intestine, the better. Bernard Dixon explains how it can be encouraged
Monday 10 January 1994
Glenn Gibson and colleagues at the Medical Research Council's Dunn Nutrition Centre in Cambridge believe it may be possible to alter the huge population of microbes growing in the large intestine so that disease-causing invaders cannot become established there.
One starting point for the research was the discovery that the mixture of bacteria in the intestines of breast-fed babies differs significantly from that of bottle-fed ones, and indeed adults. The main difference is that some 95 per cent of the intestinal flora of breast-fed babies consists of bifidobacteria (so called because their cells are often bifurcated - Y-shaped). The percentage is lower in babies given bottled milk. It also declines on weaning, and falls to some 25 per cent in the adult, when bacteria such as Escherichia coli predominate.
The full significance of bifidobacteria was not recognised, because unlike E coli they grow in the absence, rather than the presence, of oxygen. This meant that laboratory techniques for culturing bacteria from faeces tended to underestimate the numbers of bifidobacteria. Now, however, there are good reasons to believe that their presence contributes to the health advantages of breast as against bottle-feeding.
There are several possible reasons for this. Bifidobacteria produce lactic and acetic acid, which impair the growth of bacteria such as Clostridium perfringens, the agent of one type of food poisoning. They produce several vitamins and enzymes that play a role in digestion. And they are powerful stimulators of the body's immune defences.
Dr Gibson and his colleagues are now investigating the possibility of stimulating the growth of beneficial organisms such as bifidobacteria in the large intestine, so that they comprise a greater fraction of the population. By manipulating the microbial flora in this way, they believe they may be able to replicate the sort of health benefits observed in breast-fed babies. Their hopes are enhanced by reports that the bacterial community in the gut, which may be impoverished in patients receiving intensive antibiotic therapy, can be restored if they are given cultures of bifidobacteria to swallow.
The strategy being developed is to administer not the bacteria themselves but substances which, after passing unchanged through the stomach, arrive in the large intestine and stimulate the growth of bifidobacteria already there. Two of these substances are inulin and oligofructose, types of sugar that occur naturally in vegetables and other plants. Dr Gibson and his colleagues have used them in two sets of experiments. First, they prepared 'faecal slurries' from human volunteers and demonstrated that when they incubated these in the presence of inulin or oligofructose the bifidobacteria in the samples grew vigorously, while other bacteria, including those capable of causing disease, remained at low levels. Tests with pure cultures confirmed that bifidobacteria directly inhibited the growth of E coli and C perfringens.
Very recently, these results in laboratory glassware have been augmented by successful experiments in human volunteers. They were given a diet enriched firstly by ordinary sugar, followed by either inulin or oligofructose, and finally by sugar again. The experimenters monitored the bacteria in the volunteers' faeces. In each case, there was a marked shift in the bacterial flora, bifidobacteria becoming dominant during the period when the subjects were consuming the diet supplemented by inulin or oligofructose.
The lesson is clear. It is feasible, as Dr Gibson hoped, to alter the balance of bacteria in the human large intestine in such a way as to favour bifidobacteria, which are known to confer health benefits. This raises the possibility of adjusting the human diet by replacing ordinary sugar with inulin or oligofructose as a means of reducing, in the long term, the toll of intestinal infection. Inulin and oligofructose are safe and acceptable as sweeteners, though somewhat less sweet than ordinary sugar.
The upshot could, therefore, be a combination of health benefits conferred by an altered microbial population in the large intestine, and a simple means of avoiding the obesity, dental caries and other health hazards associated with over-consumption of sugar.
Diving in at the deep end is no excuse for shirking the style stakes
- 2 Why I'm on the brink of burning my Israeli passport
- 4 War is war: Why I stand with Israel
- 5 Blackest is the new black: Scientists have developed a material so dark that you can't see it...
Ian Thorpe gay: Olympic swimmer comes out in Parkinson interview
Stephen Fry ‘criticises Operation Yewtree in dinner party rant’ calling for tougher laws to deter false sex abuse allegations
Israel-Gaza conflict: ‘Sderot cinema’ image shows Israelis with popcorn and chairs 'cheering as missiles strike Palestinian targets'
Israel-Gaza conflict: Israeli air strike destroys home for the disabled killing two women residents
Israel-Gaza conflict: Israeli PM says conflict may 'continue for a long time' as hundreds of Palestinians flee their homes
Sustained immigration has not harmed Britons' employment, say government advisers
War is war: Why I stand with Israel
7/7 memorial defaced on anniversary of 2005 attacks with ‘Blair lied thousands died’ graffiti
Australia facing international condemnation after turning around Sri Lankans at sea
Even when it brutalises one of its own teenage citizens, America is helpless against Israel
Socialist Worker called to apologise over ‘vile’ article saying Eton schoolboy Horatio Chapple's death is ‘reason to save the polar bears’
£40000 - £60000 per annum + Benefits + Bonus: Harrington Starr: Dynamics CRM D...
£40000 - £45000 per annum + Benefits + Bonus: Harrington Starr: Web Developer ...
£50000 - £67000 per annum + Benefits + Bonus: Harrington Starr: C# R&D .NE...
£40000 - £50000 per annum + Benefits + Bonus: Harrington Starr: C# Developer (...